Table 2.
Values of serum variables before and after the intervention
| Placebo | MFGM | ANOVA (G × T) | ||
|---|---|---|---|---|
| P -value | ||||
| Aspartate aminotransferase, IU/L | baseline | 24.5 ± 1.82 | 22.1 ± 0.98 | 0.591 |
| 5 weeks | 25.1 ± 2.53 | 22.3 ± 0.77 | ||
| 10 weeks | 24.1 ± 1.52 | 22.7 ± 1.06 | ||
| Δ 10 weeks (%)a | 1.0 ± 5.3 | 5.1 ± 5.0 | ||
| Alanine aminotransferase, IU/L | baseline | 25.1 ± 4.33 | 20.1 ± 2.02 | 0.674 |
| 5 weeks | 23.7 ± 4.49 | 18.8 ± 2.03 | ||
| 10 weeks | 22.9 ± 2.79 | 19.7 ± 2.38 | ||
| Δ 10 weeks (%)a | - 0.1 ± 7.3 | 1.7 ± 6.6 | ||
| Glucose, mg/dl | baseline | 93.3 ± 2.01 | 90.4 ± 2.13 | 0.827 |
| 5 weeks | 93.4 ± 2.81 | 90.5 ± 2.21 | ||
| 10 weeks | 90.4 ± 2.22 | 88.6 ± 1.96 | ||
| Δ 10 weeks (%)a | - 3.0 ± 1.8 | - 1.8 ± 1.2 | ||
| Triglyceride, mg/dl | baseline | 132 ± 12.7 | 104 ± 9.4 | 0.536 |
| 5 weeks | 103 ± 10.2 | 89 ± 6.4 | ||
| 10 weeks | 109 ± 10.9 | 95 ± 8.6 | ||
| Δ 10 weeks (%)a | - 12.3 ± 6.7 | - 2.6 ± 8.9 | ||
| Total cholesterol, mg/dl | baseline | 206 ± 9.2 | 219 ± 9.8 | 0.190 |
| 5 weeks | 210 ± 10.8 | 221 ± 9.8 | ||
| 10 weeks | 211 ± 9.9 | 212 ± 7.5 | ||
| Δ 10 weeks (%)a | 2.9 ± 2.3 | - 2.0 ± 2.0 |
MFGM, milk fat globule membrane; ANOVA, analysis of variance.
Values are means ± SEM of 16 (placebo group [women, n = 7; men, n = 9]) and 19 (MFGM group [women, n = 11; men, n = 8]) subjects.
aThe value is the percentage change from the baseline to 10 weeks. Repeated-measures ANOVA for the group-by-time interaction (G × T) during the interventional period.